Goodwin

Danielle Fong

Deals
5
Latest
May 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 5 deals
Deals by year
Danielle Fong: deals by year0520252026 YTD: 5 M&A52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Danielle Fong was named on, most recent first
May 2026 LimmaTech Biologics AG –Eli Lilly and CompanyAcquisitionLegal adviser to LimmaTech Biologics AG (target)Pending780.0BiotechEli Lilly and Company acquisition of LimmaTech Biologics AG
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Kelonia Therapeutics (target)Announced7,000.0Biotech+2Eli Lilly and Company acquisition of Kelonia Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis
Apr 2026 Document Crunch –TrimbleAcquisitionLegal adviser to Document Crunch (target)Announced–Vertical SaaS+2Trimble acquisition of Document Crunch
Jan 2026 XConn –MarvellAcquisitionLegal adviser to XConn Technologies (target)Completed540.0Hardware & SemiconductorsMarvell acquisition of XConn

Deals where Danielle Fong is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.